The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis
Open accessAbstract
Importance: Despite increasing emphasis on conservative management of patent ductus arteriosus (PDA) in preterm infants, different pharmacotherapeutic interventions are used to treat those developing a hemodynamically significant PDA. Objectives: To estimate the relative likelihood of hemodynamically significant PDA closure with common pharmacotherapeutic interventions and to compare adverse event rates. Data Sources and Study Selection: The databases of MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched from inception until August 15, 2015, and updated on December 31, 2017, along with conference proceedings up to December 2017. Randomized clinical trials that enrolled preterm infants with a gestational age younger than 37 weeks treated with intravenous or oral indomethacin, ibuprofen, or acetaminophen vs each other, placebo, or no treatment for a clinically or echocardiographically diagnosed hemodynamically significant PDA. Data Extraction and Synthesis: Data were independently extracted in pairs by 6 reviewers and synthesized with Bayesian random-effects network meta-analyses. Main Outcomes and Measures: Primary outcome: hemodynamically significant PDA closure; secondary: included surgical closure, mortality, necrotizing enterocolitis, and intraventricular hemorrhage. Results: In 68 randomized clinical trials of 4802 infants, 14 different variations of indomethacin, ibuprofen, or acetaminophen were used as treatment modalities. The overall PDA closure rate was 67.4% (2867 of 4256 infants). A high dose of oral ibuprofen was associated with a significantly higher odds of PDA closure vs a standard dose of intravenous ibuprofen (odds ratio [OR], 3.59; 95% credible interval [CrI], 1.64-8.17; absolute risk difference, 199 [95% CrI, 95-258] more per 1000 infants) and a standard dose of intravenous indomethacin (OR, 2.35 [95% CrI, 1.08-5.31]; absolute risk difference, 124 [95% CrI, 14-188] more per 1000 infants). Based on the ranking statistics, a high dose of oral ibuprofen ranked as the best pharmacotherapeutic option for PDA closure (mean surface under the cumulative ranking [SUCRA] curve, 0.89 [SD, 0.12]) and to prevent surgical PDA ligation (mean SUCRA, 0.98 [SD, 0.08]). There was no significant difference in the odds of mortality, necrotizing enterocolitis, or intraventricular hemorrhage with use of placebo or no treatment compared with any of the other treatment modalities. Conclusions and Relevance: A high dose of oral ibuprofen was associated with a higher likelihood of hemodynamically significant PDA closure vs standard doses of intravenous ibuprofen or intravenous indomethacin; placebo or no treatment did not significantly change the likelihood of mortality, necrotizing enterocolitis, or intraventricular hemorrhage. Trial Registration: PROSPERO Identifier: CRD42015015797.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Inference from iterative simulation using multiple sequences
Gelman, A., & Rubin, D. B. (1992) · Statistical Science · doi:10.1214/ss/1177011136 · Cited by 16,627
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269 · cited 1×
“This study complies with the recommendations of the International Society for Pharmacoeconomics and Outcomes Research guidance on network meta-analysis and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension statement for reporting of systematic reviews incorporating network metaanalysis o…”
MethodPapile, L.-A., Burstein, J., Burstein, R., & Koffler, H. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80282-0 · Cited by 6,430
WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility
Lunn, D. J., Thomas, A., Best, N., & Spiegelhalter, D. (2000) · Statistics and Computing · doi:10.1023/a:1008929526011 · Cited by 5,368
Salanti, G., Ades, A. E., & Ioannidis, J. P. A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.016 · Cited by 3,766
Neonatal Necrotizing Enterocolitis: Therapeutic Decisions Based upon Clinical Staging
BELL, M. J., TERNBERG, J. L., FEIGIN, R. D., KEATING, J. P., MARSHALL, R., BARTON, L., & BROTHERTON, T. (1978) · Annals of Surgery · doi:10.1097/00000658-197801000-00001 · Cited by 3,514
Checking consistency in mixed treatment comparison meta-analysis
Dias, S., Welton, N. J., Caldwell, D. M., & Ades, A. E. (2010) · Statistics in Medicine · doi:10.1002/sim.3767 · Cited by 2,521 · cited 1×
“The consistency assumption among the combined sources of evidence in the network was first evaluated globally for the entire network using the design × treatment interaction model, and then locally for each treatment comparison using the nodesplitting model.(24-26) The mean surface under the cumulative ranking (SUCRA)…”
MethodCombination of direct and indirect evidence in mixed treatment comparisons
Lu, G., & Ades, A. E. (2004) · Statistics in Medicine · doi:10.1002/sim.1875 · Cited by 2,166
Puhan, M. A., Schunemann, H. J., Murad, M. H., Li, T., Brignardello-Petersen, R., Singh, J. A., Kessels, A. G., Guyatt, G. H., & for the GRADE Working Group (2014) · BMJ · doi:10.1136/bmj.g5630 · Cited by 1,812
White, I. R., Barrett, J. K., Jackson, D., & Higgins, J. P. T. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1045 · Cited by 1,114
Conceptual and technical challenges in network meta-analysis
Cipriani, A., Higgins, J. P. T., Geddes, J. R., & Salanti, G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00008 · Cited by 1,072 · cited 2×
“Transitivity was defined as the assumption that the studies were sufficiently similar in their distribution of effect modifiers so that indirect comparisons could be used as a valid method to compare 2 treatment options.(22,23) Transitivity was assessed by subjectively comparing the distribution of the population, the…”
MethodAutomating network meta‐analysis
van Valkenhoef, G., Lu, G., de Brock, B., Hillege, H., Ades, A. E., & Welton, N. J. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1054 · Cited by 786
Evaluation of inconsistency in networks of interventions
Veroniki, A. A., Vasiliadis, H. S., Higgins, J. P., & Salanti, G. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys222 · Cited by 576 · cited 1×
“The consistency assumption among the combined sources of evidence in the network was first evaluated globally for the entire network using the design × treatment interaction model, and then locally for each treatment comparison using the nodesplitting model.(24-26) The mean surface under the cumulative ranking (SUCRA)…”
MethodSelf-citationA Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus
Van Overmeire, B., Smets, K., Lecoutere, D., Van de Broek, H., Weyler, J., De Groote, K., & Langhendries, J.-P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431001 · Cited by 447
Meta-analysis in Stata : an updated collection from the Stata journal
Palmer, T., & Sterne, J. A. C. (2015) · Medical Entomology and Zoology · Cited by 388
Jansen, J. P., Crawford, B., Bergman, G., & Stam, W. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00347.x · Cited by 385
How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis
Mills, E. J., Ioannidis, J. P. A., Thorlund, K., Schünemann, H. J., Puhan, M. A., & Guyatt, G. H. (2012) · JAMA · doi:10.1001/2012.jama.11228 · Cited by 360
Ohlsson, A., Walia, R., & Shah, S. S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003481.pub6 · Cited by 334
Jansen, J. P., Trikalinos, T., Cappelleri, J. C., Daw, J., Andes, S., Eldessouki, R., & Salanti, G. (2014) · Value in Health · doi:10.1016/j.jval.2014.01.004 · Cited by 319 · cited 1×
“This study complies with the recommendations of the International Society for Pharmacoeconomics and Outcomes Research guidance on network meta-analysis and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension statement for reporting of systematic reviews incorporating network metaanalysis o…”
MethodIsayama, T., Iwami, H., McDonald, S., & Beyene, J. (2016) · JAMA · doi:10.1001/jama.2016.10708 · Cited by 310
Clyman, R. I., Couto, J., & Murphy, G. M. (2012) · Seminars in Perinatology · doi:10.1053/j.semperi.2011.09.022 · Cited by 292
A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus
Kluckow, M. R., Jeffery, M., Gill, A., & Evans, N. (2013) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2013-304695 · Cited by 249
Pezzati, M., Vangi, V., Biagiotti, R., Bertini, G., Cianciulli, D., & Rubaltelli, F. F. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70093-4 · Cited by 246
Neonatal Necrotizing Enterocolitis. Therapeutic Decisions Based upon Clinical Staging
Bell, M., Ternberg, J., Feigin, R., Keating, J., Marshall, R., Barton, L., & Brotherton, T. (2023) · 50 Landmark Papers every Pediatric Surgeon Should Know · doi:10.1201/b23252-17 · Cited by 230
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants
Ohlsson, A., & Shah, P. S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010061.pub2 · Cited by 227
Patel, J., Roberts, I., Azzopardi, D., Hamilton, P., & Edwards, A. D. (2000) · Pediatric Research · doi:10.1203/00006450-200001000-00009 · Cited by 225
Mosca, F., Bray, M., Lattanzio, M., Fumagalli, M., & Tosetto, C. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70060-x · Cited by 211
Brown, S., Hutton, B., Clifford, T., Coyle, D., Grima, D., Wells, G., & Cameron, C. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-110 · Cited by 209
Oncel, M. Y., Yurttutan, S., Erdeve, O., Uras, N., Altug, N., Oguz, S. S., Canpolat, F. E., & Dilmen, U. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.11.008 · Cited by 201
Akl, E. A., Sun, X., Busse, J. W., Johnston, B. C., Briel, M., Mulla, S., You, J. J., Bassler, D., Lamontagne, F., Vera, C., et al. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.04.015 · Cited by 179
Dang, D., Wang, D., Zhang, C., Zhou, W., Zhou, Q., & Wu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077888 · Cited by 176
Overmeire, B. V., de Broek, H. V., Laer, P. V., Weyler, J., & Vanhaesebrouck, P. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.110528 · Cited by 154
Vaucher, Y. E. (2002) · Pediatrics in Review · doi:10.1542/pir.23-10-349 · Cited by 134
Baker, S. G., & Kramer, B. S. (2002) · BMC Medical Research Methodology · doi:10.1186/1471-2288-2-13 · Cited by 116
Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants
Jones, L. J., Craven, P. D., Attia, J., Thakkinstian, A., & Wright, I. M. R. (2010) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2009.168682 · Cited by 100
Dash, S. K., Kabra, N. S., Avasthi, B. S., Sharma, S. R., Padhi, P., & Ahmed, J. (2015) · Indian Pediatrics · doi:10.1007/s13312-015-0677-z · Cited by 80
Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus
Bagheri, M., Niknafs, P., Sabzevari, F., Torabi, M. H., Bahmanbijari, B., Noroozi, E., & Mossavi, H. (2016) · Iranian Journal of Pediatrics · doi:10.5812/ijp.3975 · Cited by 75
Yang, B., Gao, X., Ren, Y., Wang, Y., & Zhang, Q. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3676 · Cited by 72
Management of Patent Ductus Arteriosus in Preterm Infants-Where Do We Stand?
Mitra, S., Rønnestad, A. E., & Holmström, H. (2013) · Congenital Heart Disease · doi:10.1111/chd.12143 · Cited by 54
Self-citationFakhraee, S. H., Badiee, Z., Mojtahedzadeh, S., Kazemian, M., & Kelishadi, R. (2007) · PubMed · Cited by 48
Hammerman, C., Shchors, I., Jacobson, S. H., Schimmel, M. S., Bromiker, R., Kaplan, M., & Nir, A. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31817d9bb0 · Cited by 46
Mitra, S., Flórez, I. D., Tamayo, M. E., Aune, D., Mbuagbaw, L. C. E., Veroniki, A. A., & Thabane, L. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011271 · Cited by 43
Self-citationEvaluation of inconsistency in networks of interventions
Veroniki, A. A., Vasiliadis, H. S., Higgins, J. P. T., & Salanti, G. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt106 · Cited by 22
Self-citationCan Dopamine Prevent the Renal Side Effects of Indomethacin?
Baenziger, O., Waldvogel, K., Ghelfi, D., Arbenz, U., & Fanconi, S. (1999) · Klinische Pädiatrie · doi:10.1055/s-2008-1043829 · Cited by 20
Lin, Y. J., Chen, C., Rehan, V. K., Florens, A., Wu, S. Y., Tsai, M., Kuo, Y. T., Huang, F. K., & Yeh, T. (2016) · Neonatology · doi:10.1159/000450822 · Cited by 20
Cited by
European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., et al. (2019) · Neonatology · doi:10.1159/000499361 · Cited by 1,613
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update
Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., et al. (2023) · Neonatology · doi:10.1159/000528914 · Cited by 704
Metadata
- Authors
- Mitra, S., Florez, I. D., Tamayo, M. E., Mbuagbaw, L., Vanniyasingam, T., Veroniki, A. A., Zea, A. M., Zhang, Y., Sadeghirad, B., & Thabane, L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-03-27
- Volume
- 319
- Issue
- 12
- Pages
- 1221
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2795051873
- Cited by
- 324
- References
- 48
- FWCI
- 20.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.